期刊文献+

脂多糖与干扰素α联用诱导白血病U937细胞凋亡及其机制 被引量:3

The Synergy Effects of Lipopolysaccharide and Interferon-Alpha on Apoptosis of U937 Leukemia Cells
下载PDF
导出
摘要 目的:探讨Toll样受体配体内毒素脂多糖(LPS)与干扰素(IFN)-α联用对白血病U937细胞凋亡的作用及其对caspase-8基因表达的影响。方法:将200μg/L的LPS和(或)2000U/mL的IFN-α作用于U937细胞,MTT检测细胞生长抑制率,流式细胞术(FCM)检测细胞凋亡率,半定量逆转录-聚合酶链反应(RT-PCR)法检测作用48h后U937细胞中caspase-8mRNA的表达。结果:LPS与IFN-α联用较单用LPS、IFN-α能明显抑制U937细胞增殖、增加细胞凋亡率(P<0.01),且各药物组较对照组比较差异均有统计学意义(P<0.01)。LPS与IFN-α联用48h后,caspase-8mRNA的表达水平较IFN-α组、LPS组和对照组均升高(P<0.01)。结论:LPS与IFN-α联用能有效抑制白血病细胞的增殖并诱导其凋亡,其机制可能与caspase-8的激活有关。 Objective: To study the synergy effects of lipopolysacchafide (LPS) and interferon-alpha (IFN-α) on the apoptosis of U937 cells, and its clinical mechanism thereof. Methods: U937 cells were treated with 200 μg/L LPS and (or) 2 000 U/mL IFN-α. The inhibitory rate of cells was measured by MTF assay. The apoptotic rate of cells was detected by flow cytometry (FCM). And the expression of caspase-8 mRNA after 48 h treatment was measured by reverse transcription-polymerase chain reaction (RT-PCR). Results:There were more pronounced inhibitory effects on U937 cell proliferation and in- creased apoptotic rate after using LPS and IFN-α compared with those of using LPS or IFN-α alone (P 〈 0.01), and there were significant differences between each drug groups and control group (P 〈 0.01). The expression level of caspase-8 mRNA increased significantly after 48 h treatment with LPS and IFN-α than that of LPS or IFN-α treatment alone and control group (P 〈 0.01). Conclusion: LPS in combination with IFN-α can inhibit the proliferation and induce the apoptosis of U937 leukemia cells, which may be related with the activation of caspase-8.
出处 《天津医药》 CAS 北大核心 2012年第2期105-107,共3页 Tianjin Medical Journal
基金 广西壮族自治区卫生厅自筹经费课题(项目编号:Z2010274)
关键词 白血病 U937细胞 Toll样受体 脂多糖类 干扰素Α 细胞凋亡 半胱氨酸天冬氨酸蛋白酶8 leukemia U937 cells Toll-like receptors lipopolysaccharides interferon-alpha apoptosis caspase 8
  • 相关文献

参考文献10

  • 1Webb RN,Cruse JM,Lewis RE.Differential cytokine and Toll-like receptor expression in leukemia[J].Exp Mol Pathol,2007,83(3):464-470.
  • 2Lehner M,Bailo M,Stachel D,et al.Caspase-8 dependent apoptosis induction in malignant myeloid cells by TLR stimulation in the presence of IFN-alpha[J].Leuk Res,2007,31 (12):1729-1735.
  • 3Wolska A,Lech-Maranda E,Robak T.Toll-like receptors and their role in hematologic malignancies[J].Curr Mol Med 2009,9(3):324-335.
  • 4Huang B,Zhao J,Li H,et al.Toll-like receptors on tumor cells facilitate evasion of immune surveillance[J].Cancer Res,2005,65(12):5009-5014.
  • 5Hammadi A,Billard C,Faussat AM,et al.Stimulation of iNOS expression and apoptosis resistance in B-cell chronic lymphocytic leukemia (B-CLL) cells through engagement of Toll-like receptor 7 (TLR-7) and NF-kappaB activation[J].Nitric Oxide,2008,19(2):138-145.
  • 6刘加军 陆惠玲 吕德坚 等.干扰素对U937细胞的诱导凋亡及其作用机制探讨.中国实用医学杂志,2005,:15-18.
  • 7刘加军,伍新尧,潘祥林,蔡贵庆.α干扰素联合阿糖胞苷对白血病K562细胞的诱导凋亡作用及其机制[J].中国肿瘤生物治疗杂志,2003,10(3):198-201. 被引量:8
  • 8Lakhani S,Flavell RA.Caspases and T lymphocytes:a flip of the coin[J]? Immunol Rev,2003,193(1):22-30.
  • 9Matsushita K,Wu Y,Qiu J,et al.Fas receptor and neuronal cell death after spinal cord ischemia[J].J Neurosci,2000,20(18):6879-6887.
  • 10Lion E,Smits EL,Berneman ZN,et al.Acute myeloid leukemic cell lines loaded with synthetic dsRNA trigger IFN-gamma secretion by human NK cells[J].Leuk Res,2009,33(4):539-546.

二级参考文献8

  • 1Goldman JM. Therapeutic strategies for chronic myeloid leukemia in the chronic (stable) phase[ J]. Semin Hematol, 2003, 40( 1 Suppl 2) : 10-17.
  • 2Silver RT, Peterson BL, Szatrowski TP, et al. Treatment of the chronic phase of chronic myeloid leukemia with an intermittent schedule of recombinant interferon alfa-2b and cytarabine : Results from CALGB study 9013 [ J]. Leuk Lymphoma, 2003, 44 ( 1 ) :39-48.
  • 3Lindauer M, Fischer T. Interferon-alpha combined with cytarabine in chronic myelogenous leukemia-clinical benefits [ J]. LeukLymphoma,2001, 41 (5): 523-533.
  • 4Peller S, Rotter V. TP53 in hematological cancer: Low incidence of mutations with significant clinical relevance[ J]. Hum Mutat,2003, 21(3) : 277-288.
  • 5Ohyashiki JH, Sashida G, Tauchi T, et al. Telomeres and telomerase in hematologic neoplasia [ J]. Oncogene, 2002, 21 ( 4 ) :680-687.
  • 6Nakajima A, Tauchi T, Sashida G, et al. Telomerase inhibition enhances apoptosis in human acute leukemia cells: Possibility of antitelomerase therapy[ J ]. Leukemia. 2003, 17 ( 3 ) : 560-567.
  • 7Lee SH, Kim JW, Lee HW, et al. Interferon regulatory factor-1( IRF-1 ) is a mediator for interferon-gamma induced attenuation of telomerase activity and human telomerase reverse transcriptase(hTERT) expression [ J ]. Oncogene, 2003, 22 (3) : 381-389.
  • 8Akiyama M, Yamada O, Kanda N, et al. Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitors[ J]. Cancer Lett, 2002,178(2) : 187-197.

共引文献7

同被引文献27

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部